Financials Vivo Collaboration Solutions Limited
Equities
VIVO
INE0IA701014
Integrated Telecommunications Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75 INR | 0.00% |
|
0.00% | -16.67% |
02-06 | Vivo Collaboration Solutions Limited Appoints Pardeep Singh as Chief Financial Officer | CI |
01-03 | Sanofi Picks Second Therapeutic Target Under In Vivo Collaboration With Scribe Therapeutics | MT |
Valuation
Fiscal Period: März | 2022 | 2023 |
---|---|---|
Capitalization 1 | 313.9 | 180.3 |
Enterprise Value (EV) 1 | 205.7 | 80.54 |
P/E ratio | 5.38 x | 51.7 x |
Yield | - | - |
Capitalization / Revenue | 2.45 x | 2.41 x |
EV / Revenue | 1.6 x | 1.08 x |
EV / EBITDA | 3.47 x | 35.9 x |
EV / FCF | 3,929,529 x | -7,297,145 x |
FCF Yield | 0% | -0% |
Price to Book | 2.26 x | 1.26 x |
Nbr of stocks (in thousands) | 2,015 | 2,015 |
Reference price 2 | 155.8 | 89.50 |
Announcement Date | 07/09/22 | 13/05/23 |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 90.23 | 100.1 | 148.7 | 128.3 | 74.78 |
EBITDA 1 | 1.207 | 8.852 | 47.61 | 59.22 | 2.241 |
EBIT 1 | 1.022 | 8.729 | 47.56 | 59.21 | 1.194 |
Operating Margin | 1.13% | 8.72% | 31.99% | 46.16% | 1.6% |
Earnings before Tax (EBT) 1 | 0.576 | 7.866 | 45.2 | 62.7 | 5.115 |
Net income 1 | 0.42 | 5.806 | 31.88 | 46.79 | 3.486 |
Net margin | 0.47% | 5.8% | 21.44% | 36.48% | 4.66% |
EPS 2 | 0.5680 | 4.730 | 24.41 | 28.94 | 1.730 |
Free Cash Flow | - | -7.326 | -9.353 | 52.35 | -11.04 |
FCF margin | - | -7.32% | -6.29% | 40.81% | -14.76% |
FCF Conversion (EBITDA) | - | - | - | 88.4% | - |
FCF Conversion (Net income) | - | - | - | 111.87% | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 31/08/21 | 31/08/21 | 31/08/21 | 07/09/22 | 13/05/23 |
Balance Sheet Analysis
Fiscal Period: März | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - |
Net Cash position 1 | 8.43 | 1.82 | 1.8 | 108 | 99.8 |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | - | -7.33 | -9.35 | 52.3 | -11 |
ROE (net income / shareholders' equity) | - | 115% | 116% | 50.2% | 2.47% |
ROA (Net income/ Total Assets) | - | 14.6% | 47.9% | 33% | 0.5% |
Assets 1 | - | 39.76 | 66.61 | 142 | 697.2 |
Book Value Per Share 2 | 2.870 | 6.460 | 31.90 | 69.10 | 70.80 |
Cash Flow per Share 2 | 11.50 | 1.480 | 1.220 | 31.40 | 9.520 |
Capex 1 | 0.14 | - | - | 0.25 | 2.62 |
Capex / Sales | 0.15% | - | - | 0.19% | 3.5% |
Announcement Date | 31/08/21 | 31/08/21 | 31/08/21 | 07/09/22 | 13/05/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-16.67% | 1.81M | |
+18.83% | 216B | |
+9.39% | 174B | |
+7.95% | 124B | |
-11.90% | 79.34B | |
+23.80% | 73.93B | |
-1.08% | 52.55B | |
-5.57% | 49.82B | |
-23.08% | 43.06B | |
-18.02% | 38.12B |
- Stock Market
- Equities
- VIVO Stock
- Financials Vivo Collaboration Solutions Limited